Clinical Trial Update: A Phase II Study of Doxycycline in Relapsed NHL [Phase 2]

View source ↗

Summary

Phase II trial of doxycycline in relapsed non-Hodgkin lymphoma was terminated and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Lymphoplasmacytic Lymphoma
• Mantle Cell Lymphoma
• Marginal Zone B-cell Lymphoma
• T-cell Lymphoma
• Waldenström Macroglobulinemia

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: University of Rochester | Conditions: Adult Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma Recurrent | Phase 2 | Status: TERMINATED | Results posted: 2016-12-22